FindTrial
Sign In

Comparison of longer vs shorter regimen for treatment of multi drug resistant tuberculosis

Efficacy of longer regimen vs shorter regimen in Multi Drug Resistant tuberculosis treated under Programmatic Management of Drug Resistant Tuberculosis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/01/061453
Enrollment
50
Registered
2024-01-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z163- Resistance to other antimicrobialdrugs

Interventions

Intervention1: nil: nil Control Intervention1: nil: nil

Sponsors

JAWAHARLAL NEHRU MEDICAL COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All patients diagnosed with drug-resistant tuberculosis and are under treatment at Acharya Vinoba Bhave Rural Hospital 2. Patients more than 18 years of age

Exclusion criteria

Exclusion criteria: Patients not giving consent

Design outcomes

Primary

MeasureTime frame
1. Smear and sputum conversion will be studied in patients on longer regimen vs shorter regimen in multi drug resistant tuberculosis 2. culture negativity of bacteria with duration of treatment will be studied and compared between longer vs shorter regimen 3. clinical profile, adverse effects, drug compliance and outcome in patients will be studied in these two regimens 4. Any new outcome during the course of the study will be assessedTimepoint: 8 weeks- 12 weeks—

Secondary

MeasureTime frame
To prepare best modality of treatmentTimepoint: 2 years—

Countries

India

Contacts

Public ContactAshwin Karnan

Datta Meghe Institute of Higher Education and Research

drulhasjadhav@gmail.com9970819099

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026